CoChat

Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide

Miyakoshi, Naohisa, Aizawa, Toshiaki, Sasaki, Satoshi, Ando, Shigeru, Maekawa, Shigeto, Aonuma, Hiroshi, Tsuchie, Hiroyuki, Sasaki, Hiroshi, Kasukawa, Yuji, Shimada, Yoichi · 2015 · Journal of Bone and Mineral Metabolism

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Atypical femoral fracture (AFF) often appears with bisphosphonate use. Teriparatide (TPTD) treatment may promote AFF healing, but few controlled or comparative studies have examined the effects of TPTD on healing of bisphosphonate-associated AFF. We retrospectively reviewed the medical records of 45 consecutive AFFs in 34 Japanese patients who had received oral bisphosphonates (alendronate or risedronate) for osteoporosis before AFF and had been followed for ≥12 months (range, 12-90 months). Thirty-seven complete or incomplete AFFs (82 %) were treated surgically and eight incomplete AFFs (18 %) were treated conservatively. Bisphosphonates were stopped at diagnosis. Based on TPTD use after fracture, AFFs were divided into non-TPTD (n = 24) and TPTD (n = 21) groups. Time to fracture-healing and frequency of delayed healing or non-union were compared between groups. Because fracture type (complete or incomplete) differed significantly between groups, only subanalyses for all surgically treated AFFs (complete and incomplete), surgically treated complete AFFs, and conservatively treated incomplete AFFs were performed. In subanalyses for all AFFs treated surgically, mean (± standard deviation) time to fracture healing was significantly better in the TPTD group (5.4 ± 1.5 months) than in the non-TPTD group (8.6 ± 4.7 months; P = 0.012), and the frequency of delayed healing or non-union was significantly lower in the TPTD group than in the non-TPTD group (P = 0.014). Subanalyses for surgically treated complete AFFs yielded similar results, but subanalyses for incomplete AFFs treated conservatively showed no significant differences between groups. TPTD treatment appears to significantly shorten the postoperative time to fracture healing and reduce rates of delayed healing or non-union after bisphosphonate-associated AFF.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00774-014-0617-3

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 27 references

Cited by

Items 101–115 of 115

Metadata

Authors
Miyakoshi, N., Aizawa, T., Sasaki, S., Ando, S., Maekawa, S., Aonuma, H., Tsuchie, H., Sasaki, H., Kasukawa, Y., & Shimada, Y.
Affiliations
  • Akita University (JP)
  • Ogachi Central Hospital (JP)
  • Nakadōri General Hospital (JP)
  • Akita Rosai Hospital (JP)
Corresponding author
Miyakoshi, Naohisa
Venue
Journal of Bone and Mineral Metabolism
Published
2014-09-17
Volume
33
Issue
5
Pages
553-559
ISSN
  • 0914-8779 (ISSN-L)
  • 1435-5604
OpenAlex
W1996444160
Cited by
114
References
27
Citations by year
2026: 3 · 2025: 6 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 11 · 2020: 13 · 2019: 12 · 2018: 6 · 2017: 13 · 2016: 15 · 2015: 10 · 2014: 1
FWCI
13.45
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Bone and Mineral Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
  • Health Sciences › Medicine › Oncology › Bone health and treatments
Keywords
atypical femoral fractures, teriparatide, fracture healing, osteoporosis, alendronate, risedronate, nonunion, delayed healing, bisphosphonate discontinuation, fracture surgery
MeSH terms
Aged, Aged, 80 and over, Diphosphonates, Female, Femoral Fractures, Humans, Osteoporosis, Retrospective Studies, Fracture Healing, Teriparatide, Alendronate, Bone Density Conservation Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.